The Orange Book

Abstract

Escalating drug prices are at the centre of the raging debates on the seemingly uncontrollable costs of providing healthcare. Making available generic substitutes for the more expensive, patented drugs is a core element of many healthcare cost-reduction plans. In the United States, the Orange Book serves to promote expedited entry of generic drugs into the marketplace while simultaneously protecting the interest of drug patent owners.